Search research articles
Contact Us
Filters
Showing results (171-180 of 214) with videos related to
Page
of 22
Sort By:
BMC Medicine
|
August 15, 2024
Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation
Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, et al.
Clinical Therapeutics
|
June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
Woohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.
Scientific Reports
|
October 16, 2023
Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock
Joo Hee Jeong, Hyungdon Kook, Seung Hun Lee, et al.
JACC. Asia
|
April 18, 2026
Percutaneous Coronary Intervention Guided by Optical Coherence Tomography or Intravascular Ultrasound for True Bifurcation Lesions
Seong-Bong Wee, Do-Yoon Kang, Jung-Min Ahn, et al.
Clinical Therapeutics
|
October 14, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
Han Saem Jeong, Soon Jun Hong, Jin-Man Cho, et al.
Cells
|
October 23, 2021
Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment
Seung-Cheol Choi, Ha-Rim Seo, Long-Hui Cui, et al.
Clinical Therapeutics
|
August 1, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, et al.
Frontiers in Cardiovascular Medicine
|
April 10, 2023
Two-Year clinical outcomes after coronary bifurcation stenting in older patients from Korea and Italy
Ju Hyeon Kim, Luca Franchin, Soon Jun Hong, et al.
Clinical Hypertension
|
September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
Gyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Clinical Therapeutics
|
February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 214) with videos related to
Sort By:
Page
of 22
BMC Medicine
|
August 15, 2024
Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation
Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, et al.
Clinical Therapeutics
|
June 3, 2018
Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
Woohyeun Kim, Yeonyee E Yoon, Sung-Hee Shin, et al.
Scientific Reports
|
October 16, 2023
Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock
Joo Hee Jeong, Hyungdon Kook, Seung Hun Lee, et al.
JACC. Asia
|
April 18, 2026
Percutaneous Coronary Intervention Guided by Optical Coherence Tomography or Intravascular Ultrasound for True Bifurcation Lesions
Seong-Bong Wee, Do-Yoon Kang, Jung-Min Ahn, et al.
Clinical Therapeutics
|
October 14, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
Han Saem Jeong, Soon Jun Hong, Jin-Man Cho, et al.
Cells
|
October 23, 2021
Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment
Seung-Cheol Choi, Ha-Rim Seo, Long-Hui Cui, et al.
Clinical Therapeutics
|
August 1, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, et al.
Frontiers in Cardiovascular Medicine
|
April 10, 2023
Two-Year clinical outcomes after coronary bifurcation stenting in older patients from Korea and Italy
Ju Hyeon Kim, Luca Franchin, Soon Jun Hong, et al.
Clinical Hypertension
|
September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
Gyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Clinical Therapeutics
|
February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
Page
of 22